Induced Chirality in Sulfasalazine by Complexation With Albumins: Theoretical and Experimental Study

IF 2.8 4区 化学 Q2 CHEMISTRY, ANALYTICAL
Chirality Pub Date : 2024-07-04 DOI:10.1002/chir.23696
Giulia Saneti Grandini, Valdecir Farias Ximenes, Nelson Henrique Morgon, Aguinaldo Robinson de Souza
{"title":"Induced Chirality in Sulfasalazine by Complexation With Albumins: Theoretical and Experimental Study","authors":"Giulia Saneti Grandini,&nbsp;Valdecir Farias Ximenes,&nbsp;Nelson Henrique Morgon,&nbsp;Aguinaldo Robinson de Souza","doi":"10.1002/chir.23696","DOIUrl":null,"url":null,"abstract":"<p>Through molecular recognition, drugs can interact and complex with macromolecules circulating in the body. The serum albumin transport protein, found in several mammals, has several interaction sites where these molecules can be located. The drug sulfasalazine (SSZ) is known in the literature to complex at drug site 1 (DS1) in human serum (HSA) and bovine serum (BSA) proteins. This complexation can be studied using various spectroscopic techniques. With the techniques used in this work, absorption in the ultraviolet and visible regions (UV–Vis) and electronic circular dichroism (ECD), a significant difference was observed in the results involving HSA and BSA. The application of theoretical methodologies, such as TD-DFT and molecular docking, suggests that the conformation that SSZ assumes in DS1 of the two proteins is different, which exposes it to different amino acid residues and different hydrophobicities. This difference in conformation may be related to the location of DS1 where the drug interacts or to the possibility of SSZ moving in the BSA site, due to its larger size, and moving less freely in HSA.</p>","PeriodicalId":10170,"journal":{"name":"Chirality","volume":"36 7","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirality","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/chir.23696","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Through molecular recognition, drugs can interact and complex with macromolecules circulating in the body. The serum albumin transport protein, found in several mammals, has several interaction sites where these molecules can be located. The drug sulfasalazine (SSZ) is known in the literature to complex at drug site 1 (DS1) in human serum (HSA) and bovine serum (BSA) proteins. This complexation can be studied using various spectroscopic techniques. With the techniques used in this work, absorption in the ultraviolet and visible regions (UV–Vis) and electronic circular dichroism (ECD), a significant difference was observed in the results involving HSA and BSA. The application of theoretical methodologies, such as TD-DFT and molecular docking, suggests that the conformation that SSZ assumes in DS1 of the two proteins is different, which exposes it to different amino acid residues and different hydrophobicities. This difference in conformation may be related to the location of DS1 where the drug interacts or to the possibility of SSZ moving in the BSA site, due to its larger size, and moving less freely in HSA.

Abstract Image

通过与白蛋白络合诱导磺胺沙拉嗪的手性:理论与实验研究
通过分子识别,药物可以与体内循环的大分子发生相互作用和复合。在几种哺乳动物体内发现的血清白蛋白转运蛋白有几个相互作用位点,这些分子可以位于其中。据文献记载,药物磺胺沙拉嗪(SSZ)可与人血清(HSA)和牛血清(BSA)蛋白中的药物位点 1(DS1)发生复合物作用。这种络合作用可通过各种光谱技术进行研究。本研究中使用的紫外和可见光区吸收(UV-Vis)和电子圆二色性(ECD)技术,在涉及 HSA 和 BSA 的结果中观察到了显著的差异。理论方法(如 TD-DFT 和分子对接)的应用表明,SSZ 在两种蛋白质的 DS1 中的构象不同,这使其暴露于不同的氨基酸残基和不同的疏水性。这种构象上的差异可能与药物相互作用的 DS1 位置有关,也可能与 SSZ 在 BSA 位点移动的可能性有关,因为 SSZ 的体积较大,而在 HSA 中移动的自由度较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chirality
Chirality 医学-分析化学
CiteScore
4.40
自引率
5.00%
发文量
124
审稿时长
1 months
期刊介绍: The main aim of the journal is to publish original contributions of scientific work on the role of chirality in chemistry and biochemistry in respect to biological, chemical, materials, pharmacological, spectroscopic and physical properties. Papers on the chemistry (physiochemical, preparative synthetic, and analytical), physics, pharmacology, clinical pharmacology, toxicology, and other biological aspects of chiral molecules will be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信